1. Home
  2. Azioni
  3. Stati Uniti
  4. Nasdaq
  5. Soliton, Inc.
  6. Notizie
  7. Altre lingue
    SOLY   US8342511008

SOLITON, INC.

(SOLY)
Tempo differito Nasdaq  -  22:00 15/12/2021
22.58 USD   +0.13%
2021AbbVie, Soliton fornisce alla FTC tempo extra per esaminare l'accordo proposto
MT
2021SOLITON, INC.: Roth Capital Partners dà una valutazione Neutrale
MM
2021SOLITON, INC.: Cantor Fitzgerald rivede il giudizio che diventa Neutral
MM
RiassuntoQuotazioniGraficiNotizieRatingSocietà 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su SOLITON, INC.
2021SOLITON, INC.(NASDAQCM: SOLY) dropped from S&P TMI Index
2021SOLITON, INC.: Completion of Acquisition or Disposition of Assets, Notice of Delisting or..
2021Allergan Aesthetics Completes Acquisition of Soliton
2021SOLITON, INC.(NASDAQCM: SOLY) dropped from NASDAQ Composite Index
2021SOLITON, INC.: Other Events (form 8-K)
2021Soliton Up 12% as Nasdaq Alert Says Sale to AbbVie Is Scheduled to Close Thursday
2021SOLITON, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
2021Soliton, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
2021SOLITON, INC.: Other Events (form 8-K)
2021SANUWAVE INC. ASSETS GET ANOTHER VAL: Snwv)
2021SOLITON: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA..
2021Soliton, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
2021SOLITON, INC.: Other Events (form 8-K)
2021SOLITON, INC.: Submission of Matters to a Vote of Security Holders (form 8-K)
2021SOLITON: AbbVie, Soliton Providing FTC Extra Time to Review Proposed Deal
2021SOLITON, INC.: Other Events (form 8-K)
2021ABBVIE: SANUWAVE's Valuation Could Surge After AbbVie Starts A Bidding War In The Shockwa..
2021With AbbVie Paying $550 Million For Soliton, Inc., SANUWAVE's Valuation Could Surge 12..
2021Here's Why SANUWAVE Could Be Worth Double The $550 Million AbbVie Paid For Soliton, Inc..
2021SOLITON: MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA..
2021Soliton, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021
2021SOLITON INVESTOR ALERT BY THE FORMER: Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
2021SOLITON: Reports First Quarter 2021 Results
2021SOLITON: SUPPORT AGREEMENT (Form 8-K)
2021SECTOR UPDATE: Health Care Stocks Hanging On For Modest Rise
2021SECTOR UPDATE: Health Care Stocks Extending Monday Gains, Overcoming Biotech Weakness
2021SECTOR UPDATE: Health Care
2021AbbVie's Allergan Aesthetics to Buy Soliton
2021ABBVIE: Allergan Aesthetics to Acquire Soliton for $22.60 per Share
2021SOLITON, INC.: Entry into a Material Definitive Agreement, Change in Directors or Princip..
2021SOLITON: Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio
2021SOLITON: Introducing RESONIC™
2021Soliton, Inc. Announces Introducing RESONIC™
2021SOLITON: to Report First Quarter 2021 Financial Results on May 13, 2021
2021SOLITON: Receives FDA Clearance of Special 510(k)
2021Soliton, Inc. Receives FDA Clearance of Special 510(K)
2021SOLITON, INC.: Submission of Matters to a Vote of Security Holders (form 8-K)
2021SOLITON: 501k Application for RESONIC Device Accepted by FDA
2021SOLITON: Provides Special 510(k) and Commercialization Update
2021Soliton, Inc. Provides Special 510(K) and Commercialization Update
2021SOLITON, INC.: Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
2021SOLITON: to Participate in Three Upcoming Healthcare Conferences
2021SOLITON: Initiates Second Animal Study for Potential Liver Fibrosis Treatment
2021SOLITON: Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver..
2021Soliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Live..
2021SOLITON: Reports Fourth Quarter and Full Year 2020 Results
2021Soliton, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 3..
2021SOLITON: Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device
2021Soliton Selects RESONIC™ As Brand Name for FDA-Cleared Rapid Acoustic Pulse Device
2021SOLITON: Announces RAP Treatment Reduces Effects of Liver Fibrosis by 42% in Animal Study
2021Soliton, Inc. Announces RAP Treatment Reduces Effects of Liver Fibrosis by 42% in Anima..
2021SOLITON: to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
2021SOLITON: Named Best New Technology Award at the Aesthetic Industry Association Board Meet..
2021SOLITON: President & CEO Brad Hauser Named as Aesthetic Industry Association Advisory Boa..
2021SOLITON, INC.: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ..
2021SOLITON: Receives FDA Clearance of Rapid Acoustic Pulse Technology to Treat Cellulite; Sh..
2021SOLITON: Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite
2021Soliton, Inc. Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cel..
2021SOLITON: Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibro..
2020SOLITON: Appoints Sean J. Shapiro as Vice President of Sales
2020Soliton, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
2020SOLITON: Management's discussion and analysis of financial condition and results of opera..
2020SOLITON: Names Brad Hauser Chief Executive; Shares Rise
2020Soliton, Inc. Appoints Brad Hauser as Chief Executive Officer
2020Soliton, Inc. Announces Management Changes
2020SOLITON, INC.: Change in Directors or Principal Officers, Financial Statements and Exhibi..
2020SOLITON: Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executiv..
2020SOLITON: Appoints Aesthetic Executive Veteran Brad Hauser as President and Chief Executiv..
2020SOLITON: Announces Third Quarter 2020 Financial Results and Business Update on Thursday, ..
2020SOLITON: Appoints Dr. Michael Kaminer to Board of Directors
2020Soliton Appoints Dr. Michael Kaminer to Board of Directors
2020SOLITON, INC.: Change in Directors or Principal Officers (form 8-K)
2020SOLITON: Appoints Niquette Hunt to Board of Directors
2020Soliton, Inc. Appoints Niquette Hunt to Board of Directors
2020SOLITON: Selects Lippe Taylor Group as its Public Relations and Customer Engagement Agenc..
1  2  3Succ.